文献速递甲状腺疾病

CD34+纤维细胞伪装成眼眶成纤维细胞在甲状腺相关眼病中的潜在作用

Potential Roles of CD34+ Fibrocytes Masquerading as Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

本文系统检索PubMed中关于甲状腺相关眼病(TAO)、眼眶成纤维细胞和纤维细胞参与发病机制的研究。眼眶组织存在显著细胞异质性,其中CD34+CXC趋化因子受体4+胶原I+表型的纤维细胞独特存在于TAO眼眶,可解释组织反应性和重塑。这些细胞意外表达TSH受体和甲状腺球蛋白等甲状腺特异蛋白,可能参与Graves病眼眶受累。证据支持纤维细胞在TAO发病中的作用,为靶向治疗提供可能。

要点

  • CD34+CXCR4+胶原I+纤维细胞独特存在于TAO眼眶,可能解释组织反应性和重塑。
  • 纤维细胞表达TSH受体和甲状腺球蛋白等甲状腺特异蛋白,可能参与眼眶受累。
  • 证据支持纤维细胞在TAO发病中起作用,靶向这些细胞可能恢复免疫耐受。

核心结论

  • 证据支持纤维细胞在甲状腺相关眼病(TAO)发病机制中起作用。
  • 识别眼眶中纤维细胞的存在为开发特异性靶向这些细胞的治疗提供了可能,最终或可恢复眼眶乃至全身的免疫耐受。

研究设计与样本

  • 系统检索PubMed中关于TAO、眼眶成纤维细胞和纤维细胞参与发病机制的研究。

主要发现

  • TAO眼眶组织显示明显的细胞异质性,存在推测来源于多种前体的成纤维细胞亚群。
  • 其中CD34+CXC趋化因子受体4+胶原I+表型的细胞被鉴定为纤维细胞,来源于单核细胞谱系。
  • 这些纤维细胞独特存在于TAO眼眶,有助于解释疾病中的组织反应性和特征性重塑。
  • 纤维细胞意外表达TSH受体和甲状腺球蛋白等传统认为甲状腺特异的蛋白,可能解释Graves病的眼眶受累。
  • 目前尚无信息明确证实CD34+眼眶成纤维细胞起源于循环纤维细胞,但动物模型推断其来源于骨髓。

临床怎么用

  • 认识纤维细胞在TAO眼眶中的存在,为开发特异性靶向这些细胞的治疗策略提供了依据。
  • 未来治疗或可旨在恢复眼眶局部乃至全身的免疫耐受。

局限性

  • 目前尚无信息明确确立CD34+眼眶成纤维细胞起源于循环纤维细胞。
  • 需进一步研究确定眼眶中纤维细胞的丰度和活性是否决定TAO的临床行为。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Orbital tissues in thyroid-associated ophthalmopathy exhibit particular reactivity and undergo characteristic remodeling. Mechanisms underlying these changes have remained largely unexplained. Studies have characterized orbital connective tissues and derivative fibroblasts to gain insights into local manifestations of a systemic autoimmune syndrome. EVIDENCE ACQUISITION: A systematic search of PubMed was undertaken for studies related to thyroid-associated ophthalmopathy (TAO), orbital fibroblasts, and fibrocytes involved in pathogenesis. EVIDENCE SYNTHESIS: Orbital tissues display marked cellular heterogeneity. Fibroblast subsets, putatively derived from multiple precursors, inhabit the orbit in TAO. Among them are cells displaying the CD34+CXC chemokine receptor 4+collagen I+ phenotype, identifying them as fibrocytes, derived from the monocyte lineage. Their unique presence in the TAO orbit helps explain the tissue reactivity and characteristic remodeling that occurs in the disease. Their unanticipated expression of several proteins traditionally thought to be thyroid gland specific, including the TSH receptor and thyroglobulin, may underlie orbital involvement in Graves disease. Although no currently available information unambiguously establishes that CD34+ orbital fibroblasts originate from circulating fibrocytes, inferences from animal models of lung disease suggest that they derive from bone marrow. Further studies are necessary to determine whether fibrocyte abundance and activity in the orbit determine the clinical behavior of TAO. CONCLUSION: Evidence supports a role for fibrocytes in the pathogenesis of TAO. Recognition of their presence in the orbit now allows development of therapies specifically targeting these cells that ultimately could allow the restoration of immune tolerance within the orbit and perhaps systemically.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Smith TJ. Potential Roles of CD34+ Fibrocytes Masquerading as Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy. J Clin Endocrinol Metab. 2019. PMID: 30445529. doi:10.1210/jc.2018-01493

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。